Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Siegfried Holding AG    SFZN   CH0014284498

SIEGFRIED HOLDING AG (SFZN)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 07/13 05:30:42 pm
410 CHF   -2.38%
04/24SIEGFRIED HOLDI : Ex-dividend day for
FA
03/09SIEGFRIED HOLDI : annual earnings release
2017LEADING PERSONA : Bernard A. Siegfried dies at age 83
PU
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
07/09/2018 07/10/2018 07/11/2018 07/12/2018 07/13/2018 Date
412.5(c) 418(c) 420.5(c) 420(c) 410(c) Last
14 419 14 738 11 250 23 103 17 618 Volume
-0.24% +1.33% +0.60% -0.12% -2.38% Change
More quotes
Financials (CHF)
Sales 2018 802 M
EBIT 2018 83,8 M
Net income 2018 62,9 M
Debt 2018 282 M
Yield 2018 0,61%
Sales 2019 851 M
EBIT 2019 104 M
Net income 2019 80,6 M
Finance 2019 13,7 M
Yield 2019 0,67%
P/E ratio 2018 26,35
P/E ratio 2019 20,70
EV / Sales2018 2,53x
EV / Sales2019 2,04x
Capitalization 1 745 M
More Financials
Company
Siegfried Holding AG engages in the development and manufacture of active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances.It also provides development and production services for finished dosage forms... 
More about the company
Surperformance© ratings of Siegfried Holding AG
Trading Rating : Investor Rating :
More Ratings
Latest news on SIEGFRIED HOLDING AG
04/24SIEGFRIED HOLDING AG : Ex-dividend day for
FA
03/09SIEGFRIED HOLDING AG : annual earnings release
2017LEADING PERSONALITY IN THE COMPANY&R : Bernard A. Siegfried dies at age 83
PU
2017SIEGFRIED : RAG-Stiftung converts bond and increases shareholding to 9.8%
PU
2017SIEGFRIED : Reports Higher Profit and Increased Margin for First Six Months
PU
2017SIEGFRIED HOLDING AG : half-yearly earnings release
2017SIEGFRIED : and Symphogen announce strategic collaboration in the fill and finis..
PU
2017SIEGFRIED HOLDING AG : Ex-dividend day for
FA
2017SIEGFRIED : Management Changes
PU
2017SIEGFRIED : with Jump in Sales
PU
More news
Sector news : Diagnostic & Testing Substances
07/11Brazil prosecutors allege jailed GE executive helped company partake in medic..
RE
07/11MEDTRONIC : Gets FDA Approval for Less-Invasive Heart Pump Implant Procedure
DJ
07/09BECTON DICKINSON AND : Completes Acquisition of TVA Medical
DJ
06/29ESSILOR INTERNATIONAL : Luxottica, Essilor extend deadline for merger pending Ch..
RE
06/22LUXOTTICA : Italy's Luxottica buys sun lens maker Barberini for 140 million euro..
RE
More sector news : Diagnostic & Testing Substances
Latest Tweets
07/14Republican strategist Evan Siegfried slams GOP Rep Louis Gohmert as ‘Evil For..
55
07/01Siegfried's heartache: crippled Roy may have just months to live.  
07/01Siegfried Hecker, a former head of the Los Alamos National Laboratory, made h..
17
06/28On our podcast, Siegfried Hecker, a professor at Stanford University and a fo..
16
06/27Evan Siegfried: "The crying children torn from their parents weren't just ano..
107
More tweets
Qtime:36
News from SeekingAlpha
03/15Siegfried Holdings Ltd 2017 Q4 - Results - Earnings Call Slides 
01/30Tweedy, Browne Fund Q4 2017 Commentary 
2017Siegfried Holdings reports 1H results 
2017Siegfried Holdings Ltd 2017 Q2 - Results - Earnings Call Slides 
2017Swiss Generic Manufacturer Siegfried Increased Sales And EBITDA 
Chart SIEGFRIED HOLDING AG
Duration : Period :
Siegfried Holding AG Technical Analysis Chart | SFZN | CH0014284498 | 4-Traders
Technical analysis trends SIEGFRIED HOLDING AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 351  CHF
Spread / Average Target -14%
EPS Revisions
Managers
NameTitle
Rudolf Hanko Chief Executive Officer
Andreas Casutt Chairman
Reto Suter Chief Financial Officer
René Imwinkelried Head-Technical Operations
Wolfgang Wienand Chief Scientific & Strategy Officer
Sector and Competitors
1st jan.Capitalization (M$)
SIEGFRIED HOLDING AG26.54%1 741
BIOMÉRIEUX3.09%10 649
DIASORIN SPA31.96%6 384
AUTOBIO DIAGNOSTICS CO LTD57.69%5 206
MACCURA BIOTECHNOLOGY CO LTD--.--%2 324
GETEIN BIOTECH INC37.62%1 549